181 related articles for article (PubMed ID: 16736125)
1. Treatment of early and refractory dermatomyositis with infliximab: a report of two cases.
Dold S; Justiniano ME; Marquez J; Espinoza LR
Clin Rheumatol; 2007 Jul; 26(7):1186-8. PubMed ID: 16736125
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.
Schiffenbauer A; Garg M; Castro C; Pokrovnichka A; Joe G; Shrader J; Cabalar IV; Faghihi-Kashani S; Harris-Love MO; Plotz PH; Miller FW; Gourley M
Semin Arthritis Rheum; 2018 Jun; 47(6):858-864. PubMed ID: 29174792
[TBL] [Abstract][Full Text] [Related]
3. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
Arnson Y; Dovrish Z; Hadari R; Amital H
Isr Med Assoc J; 2007 Jun; 9(6):492-3. PubMed ID: 17642406
[No Abstract] [Full Text] [Related]
4. Leflunomide as adjuvant treatment of dermatomyositis.
Boswell JS; Costner MI
J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory polymyositis and dermatomyositis.
Ytterberg SR
Curr Rheumatol Rep; 2006 Jun; 8(3):167-73. PubMed ID: 16901073
[TBL] [Abstract][Full Text] [Related]
6. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
7. Rituximab as therapy for refractory polymyositis and dermatomyositis.
Noss EH; Hausner-Sypek DL; Weinblatt ME
J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review.
Chen D; Wang XB; Zhou Y; Zhu XC
Rheumatol Int; 2013 Oct; 33(10):2455-8. PubMed ID: 23715693
[TBL] [Abstract][Full Text] [Related]
9. Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with infliximab.
Selva-O'Callaghan A; Martínez-Costa X; Solans-Laque R; Mauri M; Capdevila JA; Vilardell-Tarrés M
Rheumatology (Oxford); 2004 Sep; 43(9):1196-7. PubMed ID: 15317960
[No Abstract] [Full Text] [Related]
10. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
[TBL] [Abstract][Full Text] [Related]
11. [Current therapy for polymyositis and dermatomyositis].
Chérin P
Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
[TBL] [Abstract][Full Text] [Related]
12. Dermatomyositis with inclusion body myositis pathology.
Layzer R; Lee HS; Iverson D; Margeta M
Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
Woo TY; Callen JP; Voorhees JJ; Bickers DR; Hanno R; Hawkins C
J Am Acad Dermatol; 1984 Apr; 10(4):592-600. PubMed ID: 6715608
[TBL] [Abstract][Full Text] [Related]
15. Juvenile Idiopathic Inflammatory Myopathies.
Huber AM
Pediatr Clin North Am; 2018 Aug; 65(4):739-756. PubMed ID: 30031496
[TBL] [Abstract][Full Text] [Related]
16. [Can we predict the risk of malignancy associated with dermatomyositis?].
Gainon J; Bart PA; Waeber G
Praxis (Bern 1994); 2003 Oct; 92(41):1734-9. PubMed ID: 14587367
[TBL] [Abstract][Full Text] [Related]
17. Update on therapy for refractory dermatomyositis and polymyositis.
Villalba L; Adams EM
Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
[TBL] [Abstract][Full Text] [Related]
18. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
Efthimiou P; Schwartzman S; Kagen LJ
Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
[TBL] [Abstract][Full Text] [Related]
19. Dermatomyositis and Graves' disease.
Selva-O'Callaghan A; Mijares-Boeckh-Behrens T; Solans-Laque R; Molins-Vara T; Olivé G; Vilardell-Tarrés M
Clin Exp Rheumatol; 2001; 19(5):595-6. PubMed ID: 11579725
[No Abstract] [Full Text] [Related]
20. Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wong's dermatomyositis.
Caporali R; Cavagna L; Bellosta M; Bogliolo L; Montecucco C
Clin Rheumatol; 2004 Feb; 23(1):63-5. PubMed ID: 14749988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
